ARCHIVES

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter To End Print Edition In January

November 20, 2009

Announcement, RFA On Drug Discovery Groups Coming

December 10, 1982

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

February 23, 2007

Michelle Le Beau named director of University of Chicago Cancer Research Center.

May 7, 2004

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

November 22, 1991

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011